Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

P27707

- DCK_HUMAN

UniProt

P27707 - DCK_HUMAN

(max 400 entries)x

Your basket is currently empty.

Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)

Protein

Deoxycytidine kinase

Gene

DCK

Organism
Homo sapiens (Human)
Status
Reviewed - Annotation score: 5 out of 5- Experimental evidence at protein leveli

Functioni

Required for the phosphorylation of the deoxyribonucleosides deoxycytidine (dC), deoxyguanosine (dG) and deoxyadenosine (dA). Has broad substrate specificity, and does not display selectivity based on the chirality of the substrate. It is also an essential enzyme for the phosphorylation of numerous nucleoside analogs widely employed as antiviral and chemotherapeutic agents.2 Publications

Catalytic activityi

NTP + deoxycytidine = NDP + dCMP.4 Publications

Kineticsi

  1. KM=6.2 µM for deoxycytidine (dC)1 Publication
  2. KM=15.5 µM for cytarabine (araC)1 Publication
  3. KM=22 µM for gemcitabine (dC)1 Publication

Sites

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Binding sitei53 – 531Substrate
Binding sitei86 – 861Substrate
Binding sitei97 – 971Substrate
Active sitei127 – 1271Proton acceptorSequence Analysis
Binding sitei128 – 1281Substrate
Binding sitei133 – 1331Substrate
Binding sitei197 – 1971Substrate

Regions

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Nucleotide bindingi28 – 369ATP
Nucleotide bindingi188 – 1925ATP
Nucleotide bindingi240 – 2423ATP

GO - Molecular functioni

  1. ATP binding Source: UniProtKB-KW
  2. deoxycytidine kinase activity Source: UniProtKB
  3. drug binding Source: UniProtKB
  4. nucleoside kinase activity Source: Reactome
  5. protein homodimerization activity Source: UniProtKB

GO - Biological processi

  1. deoxyribonucleoside monophosphate biosynthetic process Source: GOC
  2. nucleobase-containing small molecule metabolic process Source: Reactome
  3. nucleotide biosynthetic process Source: GOC
  4. purine-containing compound salvage Source: Reactome
  5. purine nucleobase metabolic process Source: Reactome
  6. pyrimidine nucleobase metabolic process Source: Reactome
  7. pyrimidine nucleoside salvage Source: Reactome
  8. pyrimidine nucleotide metabolic process Source: UniProtKB
  9. small molecule metabolic process Source: Reactome
Complete GO annotation...

Keywords - Molecular functioni

Kinase, Transferase

Keywords - Ligandi

ATP-binding, Nucleotide-binding

Enzyme and pathway databases

BioCyciMetaCyc:HS08100-MONOMER.
BRENDAi2.7.1.74. 2681.
ReactomeiREACT_1923. Purine salvage.
REACT_655. Pyrimidine salvage reactions.
SABIO-RKP27707.

Names & Taxonomyi

Protein namesi
Recommended name:
Deoxycytidine kinase (EC:2.7.1.74)
Short name:
dCK
Gene namesi
Name:DCK
OrganismiHomo sapiens (Human)
Taxonomic identifieri9606 [NCBI]
Taxonomic lineageiEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo
ProteomesiUP000005640: Chromosome 4

Organism-specific databases

HGNCiHGNC:2704. DCK.

Subcellular locationi

Nucleus 1 Publication

GO - Cellular componenti

  1. cytosol Source: Reactome
  2. nucleus Source: UniProtKB-KW
Complete GO annotation...

Keywords - Cellular componenti

Nucleus

Pathology & Biotechi

Mutagenesis

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Mutagenesisi100 – 1001A → V: Strongly increased catalytic efficiency towards deoxycytidine; when associated with M-104 and A-133. 1 Publication
Mutagenesisi104 – 1041R → L: Strongly increased catalytic efficiency towards deoxythymidine; when associated with A-133. 3 Publications
Mutagenesisi104 – 1041R → M: Strongly increased catalytic efficiency towards deoxycytidine; when associated with V-100 and A-133. 3 Publications
Mutagenesisi133 – 1331D → A: Strongly increased catalytic efficiency towards deoxycytidine; when associated with V-100 and M-104. Strongly increased catalytic efficiency towards deoxythymidine; when associated with L-104. 3 Publications

Organism-specific databases

PharmGKBiPA137.

PTM / Processingi

Molecule processing

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Chaini1 – 260260Deoxycytidine kinasePRO_0000175090Add
BLAST

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Modified residuei11 – 111Phosphoserine; by CK11 Publication
Modified residuei15 – 151Phosphoserine; by CK11 Publication
Modified residuei72 – 721Phosphothreonine; by CK11 Publication
Modified residuei74 – 741Phosphoserine3 Publications

Post-translational modificationi

Phosphorylated and activated in vitro upon phosphorylation at Ser-74 by CSNK1D/CK1.3 Publications

Keywords - PTMi

Phosphoprotein

Proteomic databases

MaxQBiP27707.
PaxDbiP27707.
PeptideAtlasiP27707.
PRIDEiP27707.

PTM databases

PhosphoSiteiP27707.

Expressioni

Gene expression databases

BgeeiP27707.
CleanExiHS_DCK.
ExpressionAtlasiP27707. baseline and differential.
GenevestigatoriP27707.

Interactioni

Subunit structurei

Homodimer.5 Publications

Protein-protein interaction databases

BioGridi108001. 22 interactions.
IntActiP27707. 5 interactions.
MINTiMINT-1387532.
STRINGi9606.ENSP00000286648.

Structurei

Secondary structure

1
260
Legend: HelixTurnBeta strand
Show more details
Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Beta strandi22 – 276Combined sources
Helixi34 – 385Combined sources
Turni39 – 413Combined sources
Helixi42 – 443Combined sources
Beta strandi48 – 514Combined sources
Helixi55 – 584Combined sources
Beta strandi61 – 633Combined sources
Helixi69 – 724Combined sources
Helixi81 – 877Combined sources
Helixi89 – 11224Combined sources
Helixi115 – 1184Combined sources
Beta strandi119 – 1213Combined sources
Beta strandi123 – 1286Combined sources
Helixi130 – 1356Combined sources
Helixi137 – 1437Combined sources
Helixi149 – 17022Combined sources
Beta strandi173 – 1797Combined sources
Helixi182 – 19211Combined sources
Helixi195 – 1973Combined sources
Helixi202 – 21615Combined sources
Helixi226 – 2305Combined sources
Beta strandi233 – 2375Combined sources
Helixi242 – 25817Combined sources

3D structure databases

Select the link destinations:
PDBei
RCSB PDBi
PDBji
Links Updated
EntryMethodResolution (Å)ChainPositionsPDBsum
1P5ZX-ray1.60B1-260[»]
1P60X-ray1.96A/B1-260[»]
1P61X-ray2.21B1-260[»]
1P62X-ray1.90B1-260[»]
2A2ZX-ray3.02A/B/C/D1-260[»]
2A30X-ray3.02A/B/C/D1-260[»]
2A7QX-ray2.55A1-260[»]
2NO0X-ray1.80A/B1-260[»]
2NO1X-ray1.91A/B1-260[»]
2NO6X-ray1.90A/B1-260[»]
2NO7X-ray1.70A/B1-260[»]
2NO9X-ray2.15A/B1-260[»]
2NOAX-ray1.80A/B1-260[»]
2QRNX-ray3.40A/B/C/D1-260[»]
2QROX-ray3.45A/B/C/D1-260[»]
2ZI3X-ray2.30A/B1-260[»]
2ZI4X-ray2.10A1-260[»]
2ZI5X-ray1.77A/B/C/D1-260[»]
2ZI6X-ray1.77A/B/C/D1-260[»]
2ZI7X-ray1.97A/B1-260[»]
2ZI9X-ray2.51A/B1-260[»]
2ZIAX-ray1.80A/B1-260[»]
3HP1X-ray2.31A1-260[»]
3IPXX-ray2.00A20-260[»]
3IPYX-ray2.54A/B20-260[»]
3KFXX-ray1.96A/B1-260[»]
3MJRX-ray2.10A/B/C/D1-260[»]
3QEJX-ray2.49A/B1-260[»]
3QENX-ray2.00A/B1-260[»]
3QEOX-ray1.90A/B1-260[»]
4JLJX-ray2.00A/B1-260[»]
4JLKX-ray1.89A/B1-260[»]
4JLMX-ray2.18A/B1-260[»]
4JLNX-ray2.15A/B1-260[»]
4KCGX-ray2.09A/B1-260[»]
4L5BX-ray1.94A/B1-260[»]
ProteinModelPortaliP27707.
SMRiP27707. Positions 19-260.
ModBaseiSearch...
MobiDBiSearch...

Miscellaneous databases

EvolutionaryTraceiP27707.

Family & Domainsi

Sequence similaritiesi

Belongs to the DCK/DGK family.Curated

Phylogenomic databases

eggNOGiCOG1428.
GeneTreeiENSGT00510000046588.
HOGENOMiHOG000290165.
HOVERGENiHBG006216.
InParanoidiP27707.
KOiK00893.
PhylomeDBiP27707.
TreeFamiTF324413.

Family and domain databases

Gene3Di3.40.50.300. 1 hit.
InterProiIPR002624. DNK.
IPR027417. P-loop_NTPase.
[Graphical view]
PANTHERiPTHR10513. PTHR10513. 1 hit.
PfamiPF01712. dNK. 1 hit.
[Graphical view]
PIRSFiPIRSF000705. DNK. 1 hit.
SUPFAMiSSF52540. SSF52540. 1 hit.

Sequencei

Sequence statusi: Complete.

P27707-1 [UniParc]FASTAAdd to Basket

« Hide

        10         20         30         40         50
MATPPKRSCP SFSASSEGTR IKKISIEGNI AAGKSTFVNI LKQLCEDWEV
60 70 80 90 100
VPEPVARWCN VQSTQDEFEE LTMSQKNGGN VLQMMYEKPE RWSFTFQTYA
110 120 130 140 150
CLSRIRAQLA SLNGKLKDAE KPVLFFERSV YSDRYIFASN LYESECMNET
160 170 180 190 200
EWTIYQDWHD WMNNQFGQSL ELDGIIYLQA TPETCLHRIY LRGRNEEQGI
210 220 230 240 250
PLEYLEKLHY KHESWLLHRT LKTNFDYLQE VPILTLDVNE DFKDKYESLV
260
EKVKEFLSTL
Length:260
Mass (Da):30,519
Last modified:August 1, 1992 - v1
Checksum:i626B9D2D6BED8DBC
GO

Experimental Info

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Sequence conflicti122 – 1221P → S in AAV38744. 1 PublicationCurated
Sequence conflicti122 – 1221P → S in AAV38745. 1 PublicationCurated

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
M60527 mRNA. Translation: AAA35752.1.
AK313523 mRNA. Translation: BAG36303.1.
CR536527 mRNA. Translation: CAG38764.1.
CR541876 mRNA. Translation: CAG46674.1.
BT019941 mRNA. Translation: AAV38744.1.
BT019942 mRNA. Translation: AAV38745.1.
CH471057 Genomic DNA. Translation: EAX05637.1.
BC103764 mRNA. Translation: AAI03765.1.
BC114617 mRNA. Translation: AAI14618.1.
CCDSiCCDS3548.1.
PIRiA38585.
RefSeqiNP_000779.1. NM_000788.2.
UniGeneiHs.709.

Genome annotation databases

EnsembliENST00000286648; ENSP00000286648; ENSG00000156136.
GeneIDi1633.
KEGGihsa:1633.
UCSCiuc003hfx.3. human.

Polymorphism databases

DMDMi118447.

Cross-referencesi

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
M60527 mRNA. Translation: AAA35752.1 .
AK313523 mRNA. Translation: BAG36303.1 .
CR536527 mRNA. Translation: CAG38764.1 .
CR541876 mRNA. Translation: CAG46674.1 .
BT019941 mRNA. Translation: AAV38744.1 .
BT019942 mRNA. Translation: AAV38745.1 .
CH471057 Genomic DNA. Translation: EAX05637.1 .
BC103764 mRNA. Translation: AAI03765.1 .
BC114617 mRNA. Translation: AAI14618.1 .
CCDSi CCDS3548.1.
PIRi A38585.
RefSeqi NP_000779.1. NM_000788.2.
UniGenei Hs.709.

3D structure databases

Select the link destinations:
PDBei
RCSB PDBi
PDBji
Links Updated
Entry Method Resolution (Å) Chain Positions PDBsum
1P5Z X-ray 1.60 B 1-260 [» ]
1P60 X-ray 1.96 A/B 1-260 [» ]
1P61 X-ray 2.21 B 1-260 [» ]
1P62 X-ray 1.90 B 1-260 [» ]
2A2Z X-ray 3.02 A/B/C/D 1-260 [» ]
2A30 X-ray 3.02 A/B/C/D 1-260 [» ]
2A7Q X-ray 2.55 A 1-260 [» ]
2NO0 X-ray 1.80 A/B 1-260 [» ]
2NO1 X-ray 1.91 A/B 1-260 [» ]
2NO6 X-ray 1.90 A/B 1-260 [» ]
2NO7 X-ray 1.70 A/B 1-260 [» ]
2NO9 X-ray 2.15 A/B 1-260 [» ]
2NOA X-ray 1.80 A/B 1-260 [» ]
2QRN X-ray 3.40 A/B/C/D 1-260 [» ]
2QRO X-ray 3.45 A/B/C/D 1-260 [» ]
2ZI3 X-ray 2.30 A/B 1-260 [» ]
2ZI4 X-ray 2.10 A 1-260 [» ]
2ZI5 X-ray 1.77 A/B/C/D 1-260 [» ]
2ZI6 X-ray 1.77 A/B/C/D 1-260 [» ]
2ZI7 X-ray 1.97 A/B 1-260 [» ]
2ZI9 X-ray 2.51 A/B 1-260 [» ]
2ZIA X-ray 1.80 A/B 1-260 [» ]
3HP1 X-ray 2.31 A 1-260 [» ]
3IPX X-ray 2.00 A 20-260 [» ]
3IPY X-ray 2.54 A/B 20-260 [» ]
3KFX X-ray 1.96 A/B 1-260 [» ]
3MJR X-ray 2.10 A/B/C/D 1-260 [» ]
3QEJ X-ray 2.49 A/B 1-260 [» ]
3QEN X-ray 2.00 A/B 1-260 [» ]
3QEO X-ray 1.90 A/B 1-260 [» ]
4JLJ X-ray 2.00 A/B 1-260 [» ]
4JLK X-ray 1.89 A/B 1-260 [» ]
4JLM X-ray 2.18 A/B 1-260 [» ]
4JLN X-ray 2.15 A/B 1-260 [» ]
4KCG X-ray 2.09 A/B 1-260 [» ]
4L5B X-ray 1.94 A/B 1-260 [» ]
ProteinModelPortali P27707.
SMRi P27707. Positions 19-260.
ModBasei Search...
MobiDBi Search...

Protein-protein interaction databases

BioGridi 108001. 22 interactions.
IntActi P27707. 5 interactions.
MINTi MINT-1387532.
STRINGi 9606.ENSP00000286648.

Chemistry

BindingDBi P27707.
ChEMBLi CHEMBL2447.
DrugBanki DB00242. Cladribine.
DB00631. Clofarabine.
DB00987. Cytarabine.
DB01262. Decitabine.
DB00879. Emtricitabine.
DB01073. Fludarabine.
DB00441. Gemcitabine.
DB00709. Lamivudine.
DB01280. Nelarabine.
DB00642. Pemetrexed.
DB00943. Zalcitabine.

PTM databases

PhosphoSitei P27707.

Polymorphism databases

DMDMi 118447.

Proteomic databases

MaxQBi P27707.
PaxDbi P27707.
PeptideAtlasi P27707.
PRIDEi P27707.

Protocols and materials databases

DNASUi 1633.
Structural Biology Knowledgebase Search...

Genome annotation databases

Ensembli ENST00000286648 ; ENSP00000286648 ; ENSG00000156136 .
GeneIDi 1633.
KEGGi hsa:1633.
UCSCi uc003hfx.3. human.

Organism-specific databases

CTDi 1633.
GeneCardsi GC04P071816.
HGNCi HGNC:2704. DCK.
MIMi 125450. gene.
neXtProti NX_P27707.
PharmGKBi PA137.
GenAtlasi Search...

Phylogenomic databases

eggNOGi COG1428.
GeneTreei ENSGT00510000046588.
HOGENOMi HOG000290165.
HOVERGENi HBG006216.
InParanoidi P27707.
KOi K00893.
PhylomeDBi P27707.
TreeFami TF324413.

Enzyme and pathway databases

BioCyci MetaCyc:HS08100-MONOMER.
BRENDAi 2.7.1.74. 2681.
Reactomei REACT_1923. Purine salvage.
REACT_655. Pyrimidine salvage reactions.
SABIO-RK P27707.

Miscellaneous databases

ChiTaRSi DCK. human.
EvolutionaryTracei P27707.
GeneWikii Deoxycytidine_kinase.
GenomeRNAii 1633.
NextBioi 6698.
PROi P27707.
SOURCEi Search...

Gene expression databases

Bgeei P27707.
CleanExi HS_DCK.
ExpressionAtlasi P27707. baseline and differential.
Genevestigatori P27707.

Family and domain databases

Gene3Di 3.40.50.300. 1 hit.
InterProi IPR002624. DNK.
IPR027417. P-loop_NTPase.
[Graphical view ]
PANTHERi PTHR10513. PTHR10513. 1 hit.
Pfami PF01712. dNK. 1 hit.
[Graphical view ]
PIRSFi PIRSF000705. DNK. 1 hit.
SUPFAMi SSF52540. SSF52540. 1 hit.
ProtoNeti Search...

Publicationsi

« Hide 'large scale' publications
  1. Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 58-70; 119-127 AND 189-192.
  2. "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
  3. "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)."
    Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y., LaBaer J.
    Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
  4. "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."
    Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A.
    Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
  5. Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
  6. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Tissue: Uterus.
  7. "Characterization of human deoxycytidine kinase. Correlation with cDNA sequences."
    Eriksson S., Cederlund E., Bergman T., Joernvall H., Bohman C.
    FEBS Lett. 280:363-366(1991) [PubMed] [Europe PMC] [Abstract]
    Cited for: PARTIAL PROTEIN SEQUENCE, CHARACTERIZATION.
  8. "Human deoxycytidine kinase is located in the cell nucleus."
    Johansson M., Brismar S., Karlsson A.
    Proc. Natl. Acad. Sci. U.S.A. 94:11941-11945(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: SUBCELLULAR LOCATION.
  9. Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Embryonic kidney.
  10. "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
    Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M.
    Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Cervix carcinoma.
  11. Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Cervix carcinoma.
  12. Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  13. "Casein kinase 1delta activates human recombinant deoxycytidine kinase by Ser-74 phosphorylation, but is not involved in the in vivo regulation of its activity."
    Smal C., Vertommen D., Amsailale R., Arts A., Degand H., Morsomme P., Rider M.H., Neste E.V., Bontemps F.
    Arch. Biochem. Biophys. 502:44-52(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION AT SER-11; SER-15; THR-72 AND SER-74 BY CSNK1D/CK1.
  14. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
    Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.
    Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Cervix carcinoma.
  15. Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  16. "Structure of human dCK suggests strategies to improve anticancer and antiviral therapy."
    Sabini E., Ort S., Monnerjahn C., Konrad M., Lavie A.
    Nat. Struct. Biol. 10:513-519(2003) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) IN COMPLEX WITH ADP; DEOXYCYTIDINE; ARAC AND GEMCITABINE, CATALYTIC ACTIVITY, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ALA-100; ARG-104 AND ASP-133.
  17. "The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation."
    Zhang Y., Secrist J.A. III, Ealick S.E.
    Acta Crystallogr. D 62:133-139(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) IN COMPLEX WITH ADP AND CLOFARABINE, SUBUNIT.
  18. "Nonenantioselectivity property of human deoxycytidine kinase explained by structures of the enzyme in complex with L- and D-nucleosides."
    Sabini E., Hazra S., Konrad M., Lavie A.
    J. Med. Chem. 50:3004-3014(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEXES WITH ADP; D-DEOXYCYTIDINE; L-DEOXYCYTIDINE AND EMTRICITABINE.
  19. "Structural basis for substrate promiscuity of dCK."
    Sabini E., Hazra S., Ort S., Konrad M., Lavie A.
    J. Mol. Biol. 378:607-621(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.77 ANGSTROMS) IN COMPLEXES WITH D-DEOXYADENOSINE; L-DEOXYADENOSINE; ADP AND UDP, CATALYTIC ACTIVITY, FUNCTION.
  20. "Extending thymidine kinase activity to the catalytic repertoire of human deoxycytidine kinase."
    Hazra S., Sabini E., Ort S., Konrad M., Lavie A.
    Biochemistry 48:1256-1263(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (2.31 ANGSTROMS), CATALYTIC ACTIVITY, MUTAGENESIS OF ARG-104 AND ASP-133.
  21. Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 20-260 IN COMPLEX WITH SYNTHETIC INHIBITOR.
  22. "Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analogues."
    Hazra S., Ort S., Konrad M., Lavie A.
    Biochemistry 49:6784-6790(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) IN COMPLEX WITH ADP AND 5-METHYL-DEOXYCYTIDINE, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF ARG-104 AND ASP-133.
  23. "The sugar ring of the nucleoside is required for productive substrate positioning in the active site of human deoxycytidine kinase (dCK): implications for the development of dCK-activated acyclic guanine analogues."
    Hazra S., Konrad M., Lavie A.
    J. Med. Chem. 53:5792-5800(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEX WITH ACYCLOVIR AND UDP.

Entry informationi

Entry nameiDCK_HUMAN
AccessioniPrimary (citable) accession number: P27707
Secondary accession number(s): B2R8V6, Q5TZY7, Q6FI11
Entry historyi
Integrated into UniProtKB/Swiss-Prot: August 1, 1992
Last sequence update: August 1, 1992
Last modified: November 26, 2014
This is version 140 of the entry and version 1 of the sequence. [Complete history]
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Miscellaneousi

Caution

Was shown to be phosphorylated and activated by CSNK1D/CK1 in vitro but probably not in vivo.1 Publication

Keywords - Technical termi

3D-structure, Complete proteome, Direct protein sequencing, Reference proteome

Documents

  1. Human chromosome 4
    Human chromosome 4: entries, gene names and cross-references to MIM
  2. MIM cross-references
    Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
  3. PDB cross-references
    Index of Protein Data Bank (PDB) cross-references
  4. SIMILARITY comments
    Index of protein domains and families

External Data

Dasty 3